Most Read This Week
- [177]Lu-PSMA-617 Plus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
- Impact of Proton Pump Inhibitor Use on the Outcomes of CDK4/6 Inhibitor Therapy in Patients With Breast Cancer
- MRI-Guided Optimisation of Neoadjuvant Chemotherapy Duration in Patients With Stage II to III HER2-Positive Breast Cancer
- Efficacy of Sacituzumab Govitecan and Trastuzumab Deruxtecan in Patients With Metastatic Breast Cancer With Stable and Active Brain Metastases
- Circulating Tumour DNA Dynamics During Alternating Chemotherapy and Hormonal Therapy in Patients With Metastatic Breast Cancer
Recently Updated
- Nivolumab With or Without Ipilimumab for Recurrent or Metastatic Cervical Cancer
- Hospital Mortality in Patients Receiving Cancer Therapy During the COVID-19 Pandemic
- Association of Minimal Residual Disease Status 1 Year After Autologous HCT and Lenalidomide Maintenance With Long-Term Overall Survival in Multiple Myeloma
- Lower Prevalence of Employment Seen for Survivors of Childhood Cancer
- Large Language Models Fall Short in Breast Imaging Classification